Verona Pharma

VRNA

0 Followers
$63.78 -3.74% -$2.48
14 August
Upcoming Earnings
 
Market Cap.
 
P/E
Loading...

VRNA Fair Price

$33.15
Overvalued by 60.5%
To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Verona Pharma is a UK-based biotechnology company specializing in the development of drugs targeting respiratory diseases, particularly chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. The company is focused on developing innovative therapeutic options aimed at improving lung function and reducing inflammation in the airways. Verona Pharma concentrates on researching and developing medicines that can improve the quality of life for patients suffering from these chronic respiratory conditions.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade